Your browser doesn't support javascript.
loading
Natural immunity to malaria preferentially targets the endothelial protein C receptor-binding regions of PfEMP1s.
Tewey, Madison A; Coulibaly, Drissa; Lawton, Jonathan G; Stucke, Emily M; Zhou, Albert E; Berry, Andrea A; Bailey, Jason A; Pike, Andrew; Dara, Antoine; Ouattara, Amed; Lyke, Kirsten E; Ifeonu, Olukemi; Laurens, Matthew B; Adams, Matthew; Takala-Harrison, Shannon; Niangaly, Amadou; Kouriba, Bourema; Koné, Abdoulaye K; Rowe, J Alexandra; Doumbo, Ogobara K; Patel, Jigar J; Tan, John C; Felgner, Philip L; Plowe, Christopher V; Thera, Mahamadou A; Travassos, Mark A.
Afiliación
  • Tewey MA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Coulibaly D; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali.
  • Lawton JG; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Stucke EM; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Zhou AE; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Berry AA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Bailey JA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Pike A; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Dara A; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali.
  • Ouattara A; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Lyke KE; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Ifeonu O; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Laurens MB; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Adams M; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Takala-Harrison S; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Niangaly A; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali.
  • Kouriba B; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali.
  • Koné AK; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali.
  • Rowe JA; Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh , Edinburgh, United Kingdom.
  • Doumbo OK; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali.
  • Patel JJ; Roche NimbleGen, Inc. , Madison, Wisconsin, USA.
  • Tan JC; Roche NimbleGen, Inc. , Madison, Wisconsin, USA.
  • Felgner PL; Division of Infectious Diseases, Department of Medicine, University of California , Irvine, California, USA.
  • Plowe CV; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
  • Thera MA; Malaria Research and Training Center, University of Sciences, Techniques and Technologies , Bamako, Mali.
  • Travassos MA; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland, USA.
mSphere ; 8(5): e0045123, 2023 10 24.
Article en En | MEDLINE | ID: mdl-37791774
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Malaria Falciparum / Malaria Tipo de estudio: Prognostic_studies Límite: Adult / Child / Child, preschool / Humans Idioma: En Revista: MSphere Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Malaria Falciparum / Malaria Tipo de estudio: Prognostic_studies Límite: Adult / Child / Child, preschool / Humans Idioma: En Revista: MSphere Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos